Accendra Health (NYSE:ACH) Issues Quarterly Earnings Results

Accendra Health (NYSE:ACH) issued its quarterly earnings results on Monday. The company reported ($0.19) earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of $613.23 million during the quarter. Accendra Health had a negative return on equity of 13.18% and a negative net margin of 39.84%.

Accendra Health Trading Up 5.4%

ACH stock opened at $2.95 on Monday. The stock has a market cap of $225.91 million, a P/E ratio of -0.21, a P/E/G ratio of 4.32 and a beta of 1.58. The business has a fifty day moving average price of $3.19. Accendra Health has a 1 year low of $1.84 and a 1 year high of $7.10.

Wall Street Analyst Weigh In

ACH has been the topic of several analyst reports. Zacks Research raised Accendra Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 21st. UBS Group lifted their price target on Accendra Health from $3.00 to $4.50 and gave the stock a “neutral” rating in a research report on Tuesday, May 12th. Citigroup dropped their price target on shares of Accendra Health from $5.00 to $4.50 and set a “buy” rating on the stock in a research note on Friday, July 24th. Robert W. Baird increased their price objective on shares of Accendra Health from $5.00 to $6.00 and gave the company an “outperform” rating in a research report on Tuesday, May 12th. Finally, Weiss Ratings lowered shares of Accendra Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $5.00.

Hedge Funds Weigh In On Accendra Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of Accendra Health during the second quarter worth approximately $18,824,000. Bank of America Corp DE purchased a new position in Accendra Health in the 1st quarter worth $7,768,000. Dimensional Fund Advisors LP purchased a new stake in Accendra Health during the 1st quarter valued at about $5,943,000. Paradigm Capital Management Inc. NY acquired a new position in shares of Accendra Health in the first quarter valued at about $4,073,000. Finally, Renaissance Technologies LLC acquired a new position in shares of Accendra Health in the first quarter valued at about $725,000.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.